Drugs / Stemis™
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07462819 | Apr 2026 → Sep 2028 expected | — | Ji Yan Biomedical Co., Ltd. | Not yet recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Stemis | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07462819 ↗ |
| Modality | Cell therapy | “investigational cell therapy product” NCT07462819 ↗ |
| Route | Intravenous | “administered by intravenous infusion” NCT07462819 ↗ |